Civitas Investigational Site 1001 — Bingham Farms, Michigan

Civitas Investigational Site 1001 is a clinical research site located in Bingham Farms, Michigan, United States 48025.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Civitas Investigational Site 1001 has participated in 1 clinical trials.

Therapeutic areas: Idiopathic Parkinson's Disease.

Sponsors: Acorda Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bingham Farms

Browse all research sites in Michigan · View every site in Bingham Farms

• William Beaumont Hospital
• QUEST Research Institute
• GSK Investigational Site
• Research Site
• Pfizer Investigational Site
• Michigan Center of Medical Research
• BioSante Site 124
• Detroit Clinical Research Center, P.C.
• XenoPort Clinical Site
• QUEST Research Institiute
• Acorda Site #5002
• Kresge Eye Institute

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Civitas Investigational Site 1001?

Civitas Investigational Site 1001 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Civitas Investigational Site 1001 conducted?

Civitas Investigational Site 1001 has 1 clinical trials on record. Their work covers Idiopathic Parkinson's Disease.

Is Civitas Investigational Site 1001 accredited by Crixeo Clinical Trials?

Civitas Investigational Site 1001 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Civitas Investigational Site 1001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.